Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Pulmonary Disease, Chronic Obstructive 1Lung Neoplasms 1Disease 1Diabetes Mellitus, Type 2 1

Interventions

Tomography, X-Ray Computed 2Hematologic Tests 2Blood Specimen Collection 2tivozanib 1pembrolizumab 1aflibercept 1Videotape Recording 1Urination 1Thoracoscopy 1Thoracic Surgical Procedures 1Sulfonylurea Compounds 1Sodium-Glucose Transporter 2 Inhibitors 1Referral and Consultation 1Octreotide 1Magnetic Resonance Spectroscopy 1Lymph Node Excision 1Ipilimumab 1Interviews as Topic 1Interleukin-15 1In Situ Hybridization 1Immunohistochemistry 1Exercise 1Erlotinib Hydrochloride 1Equipment and Supplies 1Educational Status 1Dipeptidyl-Peptidase IV Inhibitors 1Diagnostic Tests, Routine 1Diagnosis 1Clinical Laboratory Techniques 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Disease × Dipeptidyl-Peptidase IV Inhibitors × Thoracic × Clear all
NCT07332156 2026-01-14

Lung Cancer Risk in Type 2 Diabetes With COPD: SGLT2 Inhibitors vs. Sulfonylureas

Samsung Medical Center

Completed
21,692 enrolled
Thoracic

Diabetes Mellitus, Type 2, Disease, Lung Neoplasms, Pulmonary Disease, Chronic Obstructive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡